Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma
Key PointsDaily subcutaneous anakinra is insufficient to prevent grade ≥2 CRS and NT in patients receiving axicabtagene ciloleucel.Single-cell RNA sequenci